Clinical Trial Update: Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of bicalutamide and goserelin in ovarian cancer, fallopian tube cancer, or primary peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Goserelin (Goserelin)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED